Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LTB4 in HIV-1 Infected Adults
NCT00251537Phase 2Completed
- Sponsor
- LTB4 Sweden
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Leukotriene B4 in human immunodeficiency virus type 1 infection (HIV-1) (3 arms), sponsored by LTB4 Sweden. Primary endpoint: Change in viral load at 28 days. Started Nov 2005; status: completed.
02
Drugs
Leukotriene B4
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00251537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00251537.